175 related articles for article (PubMed ID: 26938029)
1. Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancer.
Jeon MJ; Gordon AC; Larson AC; Chung JW; Kim YI; Kim DH
Biomaterials; 2016 May; 88():25-33. PubMed ID: 26938029
[TBL] [Abstract][Full Text] [Related]
2. Janus "nano-bullets" for magnetic targeting liver cancer chemotherapy.
Shao D; Li J; Zheng X; Pan Y; Wang Z; Zhang M; Chen QX; Dong WF; Chen L
Biomaterials; 2016 Sep; 100():118-33. PubMed ID: 27258482
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial delivery of superparamagnetic iron-oxide nanoshell and polyvinyl alcohol based chemoembolization system for the treatment of liver tumor.
Liang Q; Wang YX; Ding JS; He W; Deng LL; Li N; Liao YJ; Li Z; Ye B; Wang W
Discov Med; 2017 Jan; 23(124):27-39. PubMed ID: 28245425
[TBL] [Abstract][Full Text] [Related]
4. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
[TBL] [Abstract][Full Text] [Related]
5. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
6. Improved drug targeting to liver tumors after intra-arterial delivery using superparamagnetic iron oxide and iodized oil: preclinical study in a rabbit model.
Lee IJ; Ahn CH; Cha EJ; Chung IJ; Chung JW; Kim YI
Invest Radiol; 2013 Dec; 48(12):826-33. PubMed ID: 23835597
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.
Kim D; Lee JH; Moon H; Seo M; Han H; Yoo H; Seo H; Lee J; Hong S; Kim P; Lee HJ; Chung JW; Kim H
Theranostics; 2021; 11(1):79-92. PubMed ID: 33391462
[TBL] [Abstract][Full Text] [Related]
8. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Infusion of iRGD-Modified ZrO
Xie Y; Qi X; Xu K; Meng X; Chen X; Wang F; Zhong H
J Vasc Interv Radiol; 2019 Dec; 30(12):2026-2035.e2. PubMed ID: 31590966
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
Maeng JH; Lee DH; Jung KH; Bae YH; Park IS; Jeong S; Jeon YS; Shim CK; Kim W; Kim J; Lee J; Lee YM; Kim JH; Kim WH; Hong SS
Biomaterials; 2010 Jun; 31(18):4995-5006. PubMed ID: 20347138
[TBL] [Abstract][Full Text] [Related]
11. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells.
Medina SH; Chevliakov MV; Tiruchinapally G; Durmaz YY; Kuruvilla SP; Elsayed ME
Biomaterials; 2013 Jun; 34(19):4655-66. PubMed ID: 23523429
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma.
Zavareh S; Mahdi M; Erfanian S; Hashemi-Moghaddam H
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1073-1084. PubMed ID: 27752764
[TBL] [Abstract][Full Text] [Related]
14. Effect of transcatheter intraarterial therapies on the distribution of Doxorubicin in liver cancer in a rabbit model.
Liang B; Xiong F; Wu H; Wang Y; Dong X; Cheng S; Feng G; Zhou G; Xiong B; Liang H; Xia X; Zheng C
PLoS One; 2013; 8(10):e76388. PubMed ID: 24116106
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach.
Fang C; Kievit FM; Veiseh O; Stephen ZR; Wang T; Lee D; Ellenbogen RG; Zhang M
J Control Release; 2012 Aug; 162(1):233-41. PubMed ID: 22735239
[TBL] [Abstract][Full Text] [Related]
16. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
Nittayacharn P; Nasongkla N
J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
[TBL] [Abstract][Full Text] [Related]
17. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
Li Z; Zhang L; Tang C; Yin C
Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.
Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
Biomaterials; 2013 Sep; 34(27):6444-53. PubMed ID: 23755831
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
